Precirix and IFE sign clinical trial manufacturing agreementClinical Trial Manufacturing Agreement • September 13th, 2021
Brussels, Belgium and Kjeller, Norway, 13 September 2021 – Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and the Institute for Energy Technology (IFE), a manufacturer of radiopharmaceutical products based in Norway, today announced an agreement for the supply of Precirix’ radiopharmaceuticals in Europe.
CLINICAL TRIAL MANUFACTURING AGREEMENTClinical Trial Manufacturing Agreement • November 2nd, 2006 • Oramed Pharmaceuticals Inc. • Mining & quarrying of nonmetallic minerals (no fuels)
NOW THEREFORE, in consideration of the premises and the covenants and agreements set out herein, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
